12:00 AM
 | 
Apr 15, 2013
 |  BC Week In Review  |  Clinical News  |  Regulatory

Avandia rosiglitazone regulatory update

FDA's Endocrinologic and Metabolic Drugs Advisory Committee and the DrugSafety and Risk Management Advisory Committee will meet on June 5-6 to discuss the results of an independent re-adjudication of the...

Read the full 126 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >